Thu, May 19, 2022
Published: Mar 03, 2022
Chinese researchers have developed an mRNA antibody that provided long-term protection against SARS-CoV-2 in animal tests, representing a promising antibody-based therapy for COVID-19 patients.
Published: Dec 24, 2021
A third dose of AstraZenecas Covid-19 vaccine significantly boosted neutralizing antibodies against omicron, according to lab studies at the University of Oxford.
Published: Nov 18, 2021
AstraZenecas Covid-19 antibody cocktail was more than 80% successful at both preventing symptomatic disease for six months and stopping the illness from worsening, demonstrating its ability to provide strong and long-lasting protection.
Published: Sep 29, 2021
More than 2,000 hospital employees were observed for the study, and the latest findings were based on a subset of more than 460 staff, Swedish Television reported.
Published: Jun 26, 2021
The Department of Medical Sciences has advised people against buying antibody testing kits to test themselves after getting a Covid-19 vaccine, as the result could be inaccurate and might cause misunderstanding.
Published: Nov 06, 2020
Celltrion reaffirmed positive findings from the phase 1 clinical trial of its COVID-19 antibody treatment CT-P59 at the annual autumn conference of Korean societies of infectious diseases and antimicrobial therapy, the company said Friday.